ClinicalTrials.gov
public full text
Public Domain
Network Osteoporosis Study
This study is evaluating the use of the drug alendronate in preventing or reversing bone loss in children and adolescents receiving steroid medications.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Drug Holidays in the Treatment With Alendronate in Postmenopausal Women With Osteoporosis#856740
- Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients?#1321361
- The Importance of Patient Education - A Randomised Controlled Trial#968660
- Patient- and Physician-Based Osteoporosis Education#1369462
- Calcium Metabolism in Mexican American Adolescents#906277
Record · ID 1419985
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive